Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early diagnosis of malignant melanoma: Proposal of a working formulation for the management of cutaneous pigmented lesions from the Melanoma Cooperative Group.
Ascierto PA, Palmieri G, Botti G, Satriano RA, Stanganelli I, Bono R, Testori A, Bosco L, Daponte A, Caracò C, Chiofalo MG, Melucci MT, Calignano R, Tatangelo F, Cochran AJ, Castello G; Melanoma Cooperative Group. Ascierto PA, et al. Among authors: castello g. Int J Oncol. 2003 Jun;22(6):1209-15. Int J Oncol. 2003. PMID: 12738985
Soluble interleukin-2 receptor in stage I-III melanoma.
Ottaiano A, Leonardi E, Simeone E, Ascierto PA, Scala S, Calemma R, Bryce J, Caracò C, Satriano RA, Gianfranco N, Franco R, Botti G, Castello G. Ottaiano A, et al. Among authors: castello g. Cytokine. 2006 Feb 7;33(3):150-5. doi: 10.1016/j.cyto.2006.01.002. Epub 2006 Mar 6. Cytokine. 2006. PMID: 16517174
Role of interferons in the therapy of melanoma.
Castello G, Ruocco V, Satriano RA, Zarrilli D. Castello G, et al. Melanoma Res. 1992 Jan-Feb;1(5-6):311-25. doi: 10.1097/00008390-199201000-00002. Melanoma Res. 1992. PMID: 1384854 Review.
Intermediate dose recombinant interferon-alpha as second-line treatment for patients with recurrent cutaneous melanoma who were pretreated with low dose interferon.
Ascierto PA, Daponte A, Parasole R, Perrone F, Caracò C, Melucci M, Palmieri G, Napolitano M, Mozzillo N, Castello G. Ascierto PA, et al. Among authors: castello g. Cancer. 2000 Oct 1;89(7):1490-4. doi: 10.1002/1097-0142(20001001)89:7<1490::aid-cncr11>3.0.co;2-v. Cancer. 2000. PMID: 11013362 Clinical Trial.
220 results